The Cancer Screening Committee
- deals with questions surrounding population-based cancer screenings
- independently assesses scientific evidence and observes developments in Switzerland and abroad
- considers medical indications, epidemiological, economic, legal and ethical aspects, as well as the interests of patients
- formulates recommendations for cancer screening measures
Composition of the Committee of Experts
| Epidemiology, Methodology, Statistics | Prof. Dr. Marcel Zwahlen, Institute for Social and Preventive Medicine, University of Bern, Chairman of the Cancer Screening Committee Prof. Dr. med. Thomas Agoritsas, Divisions of Internal Medicine & Clinical Epidemiology, Geneva University Hospitals |
| Medicine (Clinical Practice and Prevention) | Prof. Dr. med. Stefan Aebi, Chief physician of medical oncology, Lucerne Cantonal Hospital Prof. Dr. med. Reto Auer, Institute of Primary Health Care (BIHAM), University of Bern, Center for Primary Care and Public Health (Unisanté), Lausanne Dr. med. Reto Guetg, Independent medical examiner, medical advisor Federal law on Health Insurance, Bern |
| Screening | Dr. med. Jacques Fracheboud, retired, formerly Erasmus University Medical Center, Rotterdam, The Netherlands |
| Health Economics | Prof. Dr. Matthias Schwenkglenks, Institute of Pharmaceutical Medicine, University of Basel, Institute of Epidemiology, Biostatistics and Prevention, University of Zurich |
| Ethics | Prof. Dr med. Samia Hurst-Majno, Institute for ethics, history and the humanities, University of Geneva |
| Law and Ethics | lic. iur. Michelle Salathé, Medicine Ethics Law, Basel |
| Patient partner | David U. Haerry, Chairman Positive Council, European Patients Academy (EUPATI), Zurich |